Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

19.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A ratiometric fluorescent reporter of mitochondrial sodium.

Nature chemical biology·2026
Same author

Organelles harbour pH gradients.

Research square·2026
Same author

Organelles harbour pH gradients.

bioRxiv : the preprint server for biology·2025
Same author

An SLC12A9-dependent ion transport mechanism maintains lysosomal osmolarity.

Developmental cell·2024
Same author

Lightly counting membrane proteins in native nanodiscs.

Nature nanotechnology·2023
Same author

A DNA nanodevice for mapping sodium at single-organelle resolution.

Nature biotechnology·2023

Related Experiment Video

Updated: Mar 11, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.5K

Platinum complexes as light promoted anticancer agents: a redefined strategy for controlled activation.

Koushambi Mitra1

  • 1Department of Inorganic and Physical Chemistry, Indian Institute of Science, Bangalore 560-012, India. kmitra@ipc.iisc.ernet.in.

Dalton Transactions (Cambridge, England : 2003)
|November 25, 2016
PubMed
Summary

Researchers are developing light-activated platinum prodrugs for targeted cancer therapy. This approach enables precise drug activation within tumors, minimizing side effects and enhancing treatment efficacy for better patient outcomes.

More Related Videos

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

59.1K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.9K

Related Experiment Videos

Last Updated: Mar 11, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.5K
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

59.1K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.9K

Area of Science:

  • Inorganic Chemistry
  • Medicinal Chemistry
  • Photochemistry

Background:

  • Platinum-based drugs are mainstays in cancer chemotherapy.
  • Platinum(IV) prodrugs offer advantages over platinum(II) but can cause non-specific cytotoxicity.
  • Targeted drug activation is crucial for improving efficacy and reducing side effects.

Purpose of the Study:

  • To review research on platinum complexes with light-mediated anticancer effects.
  • To explore mechanisms of photoactivation for controlled drug delivery.
  • To highlight strategies for developing advanced platinum-based anticancer agents.

Main Methods:

  • Literature review of photoactive platinum complexes.
  • Analysis of coordination sphere modifications affecting redox and spectral properties.
  • Examination of light-promoted activation strategies: photoreduction, photocaging, photodissociation, and photosensitization.

Main Results:

  • Photoactivation of platinum prodrugs allows spatio-temporal control of drug release within tumors.
  • Modulating coordination spheres alters electronic and cellular properties of platinum complexes.
  • Light-mediated strategies can release active platinum(II) and/or reactive oxygen species.

Conclusions:

  • Photoactive platinum complexes offer targeted cancer treatment by activating drugs specifically within neoplastic cells.
  • Dual-action photoactive metal complexes show promise for combination therapy.
  • Further development of these versatile agents could significantly advance anticancer research and treatment.